as on March 11, 2026 at 6:59 am IST
Day's Low
Day's High
0.10%
Downside
1.93%
Upside
52 Week's Low
52 Week's High
44.21%
Downside
16.96%
Upside
Check Incyte Corporation market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$19.3B
EPS (TTM)
7.4162
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.44%
PE Ratio (TTM)
15.15
Industry PE ratio
17.50525641025641
PEG Ratio
0.3342
EBITDA
1.4B
Revenue (TTM)
5.1B
Profit Margin
25.03%
Return On Equity TTM
29.87%
Track how Incyte Corporation P/E has moved over time to understand its valuation trends.
Incyte Corporation in the last 5 years
Lowest (13.04x)
September 30, 2025
Today (15.15x)
March 11, 2026
Industry (17.51x)
March 11, 2026
Highest (151.83x)
September 30, 2024
Today’s Price to Earnings Ratio: 15.15x
Compare market cap, revenue, PE, and other key metrics of Incyte Corporation with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $19.3B | 20.81% | 15.15 | 25.03% | |
| BUY | $42.9B | 125.47% | 138.88 | 8.45% | |
| BUY | $117.1B | 132.01% | 30.12 | 32.94% | |
| NA | $34.9B | NA | 121.89 | 5.37% | |
| BUY | $82.6B | 64.28% | 18.83 | 31.41% |
The Incyte Corporation stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Incyte Corporation investment value today
Current value as on today
₹1,46,238
Returns
₹46,238
(+46.24%)
Returns from Incyte Corporation Stock
₹41,046 (+41.05%)
Dollar Returns*
₹5,192 (+5.19%)
Based on 29 analysts
55.17%
Buy
44.83%
Hold
0.00%
Sell
Based on 29 analysts, 55.17% of analysts recommend a 'BUY' rating for Incyte Corporation. Average target price of $108.77
Get share price movements and forecasts by analysts on Incyte Corporation.
What analysts predicted
11.73%UPSIDE
Target Price
$108.77
Current Price
$96.01
Analyzed by
29 Analysts
Target
$108.77
Incyte Corporation target price $108.77, a slight upside of 11.73% compared to current price of $96.01. According to 29 analysts rating.
Search interest for Incyte Corporation Stock has decreased by -40% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 10 February
Tue, 08:00 PM
-Incyte reports Q4 revenue of $1.51 billion, exceeding estimates, but EPS of $1.80 misses consensus by 7.06%.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Revenue is up for the last 4 quarters, 1.05B → 1.50B (in $), with an average increase of 11.3% per quarter
Best in 1 Year
![]()
In the last 1 year, INCY has outperformed top 5 stocks with highest market-cap in its industry
Price Rise
![]()
In the last 6 months, INCY stock has moved up by 12.7%
Against Peers
![]()
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 77.2% return, outperforming this stock by 42.4%
Profit Down
![]()
Netprofit is down for the last 2 quarters, 424.16M → 299.27M (in $), with an average decrease of 29.4% per quarter
| Organisation | Incyte Corporation |
| Headquarters | 1801 Augustine Cut-Off, Wilmington, DE, United States, 19803 |
| Industry | Health Technology |
| CEO | Mr. William J. Meury |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Ms. Alexis Smith | Vice President & Head of Investor Relations |
Mr. Richard A. Hoffman J.D., M.B.A. | Executive VP & General Counsel |
Dr. Steven H. Stein M.D. | Executive VP & Chief Medical Officer |
Mr. Thomas Tray | Principal Financial Officer, VP of Finance & Chief Accounting Officer |
Mr. Michael James Morrissey | Executive VP & Head of Global Technical Operations |
Ms. Soni K. Basi Ph.D. | Executive VP & Chief Human Resources Officer |
Mr. James H. Lee M.D., Ph.D. | Group VP, Head of Inflammation & AutoImmunity Group |
Dr. Pablo J. Cagnoni M.D., Ph.D. | President and Head of Research & Development |
Mr. William J. Meury | CEO, President & Director |
Ms. Pamela M. Murphy | Vice President of Investor Relations & Corporate Communications |
Incyte Corporation share price today is $96.01 as on at the close of the market. Incyte Corporation share today touched a day high of $97.86 and a low of $95.91.
Incyte Corporation share touched a 52 week high of $112.29 on and a 52 week low of $53.56 on . Incyte Corporation stock price today i.e. is closed at $96.01,which is 14.50% down from its 52 week high and 79.26% up from its 52 week low.
Incyte Corporation market capitalisation is $0.02T as on .
Indian investors can start investing in Incyte Corporation (INCY) shares with as little as ₹91.833 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹918.33 in Incyte Corporation stock (as per the Rupee-Dollar exchange rate as on ).
Based on Incyte Corporation share’s latest price of $96.01 as on March 11, 2026 at 1:29 am IST, you will get 0.1042 shares of Incyte Corporation. Learn more about
fractional shares .
Incyte Corporation stock has given 20.81% share price returns and 26.32% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?